Here, we describe the association of genetic variation in PFKFB3 with an increased risk for developing IPA in HSCT patients as the result of a defective metabolic reprogramming and downstream antifungal effector functions of macrophages. This evidence concerns the gene PFKFB3 and Ito hypomelanosis.